7‐Amidocoumarins as Multitarget Agents against Neurodegenerative Diseases: Substitution Pattern Modulation-Reference-Cited by-同舟云学术

7‐Amidocoumarins as Multitarget Agents against Neurodegenerative Diseases: Substitution Pattern Modulation

Published:2020-08-25 Issue:1 Volume:16 Page:179-186
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Rodríguez‐Enríquez Fernanda¹²,Viña Dolores¹²,Uriarte Eugenio³⁴,Laguna Reyes²,Matos Maria J.³⁵^ORCID

Affiliation:

1. Chronic Diseases Pharmacology Group Center for Research in Molecular Medicine and Chronic Diseases (CIMUS) University of Santiago de Compostela 15782 Santiago de Compostela Spain

2. Departamento de Farmacología, Farmacia y Tecnología Farmacéutica Universidade de Santiago de Compostela 15782 Santiago de Compostela Spain

3. Departamento de Química Orgánica Facultade de Farmacia Universidade de Santiago de Compostela 15782 Santiago de Compostela Spain

4. Instituto de Ciencias Químicas Aplicadas Universidad Autónoma de Chile 7500912 Santiago Chile

5. CIQUP/Department of Chemistry and Biochemistry Faculty of Sciences University of Porto 4169-007 Porto Portugal

Funder

Universidade do Porto

Universidade de Santiago de Compostela

Xunta de Galicia

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.202000454

Reference39 articles.

1. GBD 2016 Brain and Other CNS Cancer Collaborators Lancet Neurol.2019 18 376–393.

2. GBD 2016 Neurology Collaborators Lancet Neurol.2019 18 459–480.

3. GBD 2016 Dementia Collaborators Lancet Neurol.2019 18 88–106.

4. Changing patterns of neurological mortality in the 10 major developed countries – 1979–2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N-(coumarin-3-yl)cinnamamide Promotes Immunomodulatory, Neuroprotective, and Lung Function-Preserving Effects during Severe Malaria;Pharmaceuticals;2023-12-27

2. Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer’s disease;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-11-13

3. Propargylamine: an important moiety in drug discovery;Future Medicinal Chemistry;2023-01

4. Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer’s Disease;Journal of Medicinal Chemistry;2022-03-10

5. Coumarin-Resveratrol-Inspired Hybrids as Monoamine Oxidase B Inhibitors: 3-Phenylcoumarin versus trans-6-Styrylcoumarin;Molecules;2022-01-29